DCM
DCPH

Delpha Capital Management’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History

Delpha Capital Management’s Portfolio DCPH Stock Details DCPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-462
Closed -$10K – 1312
2017
Q4 		$10K Buy
+462
New +$9.05K 0.01% 1090

Other funds holding DCPH

NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
SHI
SV Health Investors Boston, Massachusetts $32.3M AUM 20.15% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EA
Emerald Advisers Leola, Pennsylvania $4.25B AUM 141.71% 1-Year Est. Return
EMFAT
Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.85B AUM 140.52% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return

Delpha Capital Management's DCPH Position: Q1 2018 in Review

Delpha Capital Management sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q1 2018, closing a stake of 462 shares — an estimated $10K sold.

Delpha Capital Management first reported a position in DCPH in Q4 2017 and held it in 1 quarter. The position peaked at $10K in Q4 2017. 55 funds tracked by Wall St. Rank hold DCPH as of Q1 2018.

  • Delpha Capital Management reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
  • Delpha Capital Management sold 462 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q1 2018, an estimated $10K.
  • Delpha Capital Management first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q4 2017 and held it in 1 quarter.
  • Delpha Capital Management's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $10K in Q4 2017.
  • 55 funds tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q1 2018.

Based on Delpha Capital Management's 13F filing for Q1 2018, filed 11 May 2018.